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Summary
TGF- signaling is essential for development and pro-
liferative homeostasis. During embryogenesis, mater-
nal determinants act in concert with TGF- signals to
form mesoderm and endoderm. In contrast, ectoderm
specification requires the TGF- response to be at-
tenuated, although the mechanisms by which this is
achieved remain unknown. In a functional screen for
ectoderm determinants, we have identified Ecto-
dermin (Ecto). In Xenopus embryos, Ecto is essential
for the specification of the ectoderm and acts by re-
stricting the mesoderm-inducing activity of TGF-
signals to the mesoderm and favoring neural induc-
tion. Ecto is a RING-type ubiquitin ligase for Smad4,
a TGF- signal transducer. Depletion of Ecto in hu-
man cells enforces TGF--induced cytostasis and,
moreover, plays a causal role in limiting the antimito-
genic effects of Smad4 in tumor cells. We propose
that Ectodermin is a key switch in the control of
TGF- gene responses during early embryonic devel-
opment and cell proliferation.
Introduction
During early vertebrate development, the fate of initially
pluripotent cells becomes progressively restricted to
more and more limited developmental choices. A fun-
damental step in this process is the allocation of cells
to the primary germ layers: ectoderm, mesoderm, and
endoderm.
Seminal work in Xenopus has shown that, through
uneven cell divisions, maternal “determinants” located
asymmetrically in the egg are differentially inherited by
distinct groups of cells; such initial differences are am-
plified and ultimately fixed by growth-factor signaling
(De Robertis et al., 2000; Harland and Gerhart, 1997;
Zhang et al., 1998). This represents an attractive para-
digm of cell-fate decision in which intrinsic and extrin-
sic cues interact with each other to generate a coherent
embryonic patterning. Over the last decade, substantial
progress has been made in the identification of key*Correspondence: piccolo@civ.bio.unipd.itevents leading to mesoderm and endoderm formation.
In Xenopus embryos, maternal determinants, such as
VegT or Vg1, are localized in the vegetal hemisphere,
where they activate the transcription of TGF-β/nodal
signals responsible for inducing the mesoderm in the
overlying marginal-zone cells at the equator of the
embryo (Figure 1A) (Piccolo et al., 1999; Whitman, 2001).
Very little is known about genes essential for the
specification of the ectoderm germ layer. The existence
of determinants important for ectoderm development is
suggested by the phenotype of embryos depleted of
VegT (Zhang et al., 1998), where the marginal zone dif-
ferentiates as ectoderm instead of mesoderm. Thus, a
specific set of signals is required for ectoderm develop-
ment, including molecules able to antagonize meso-
derm formation (Wessely and De Robertis, 2000).
Embryological experiments indicate that ectoderm
cells remain pluripotent until gastrulation (Snape et al.,
1987); at this stage, the ectoderm would generate, by
“default,” neural tissue unless induced to form epider-
mis by BMP ligands (Piccolo et al., 1996; Zimmerman
et al., 1996). These data strongly suggest that ectoderm
development requires a strict control of the signaling
and gene responses triggered by TGF-β superfamily
members.
TGF-β ligands transmit the signal intracellularly to the
receptor-Smad family of signal transducers (R-Smads).
The TGF-β and BMP signaling branches make use of
distinct R-Smads but converge in the common media-
tor Smad4, which forms a complex with R-Smads in
the nucleus to regulate transcription of target genes. In
adult tissues, TGF-β signaling is crucial for maintaining
proliferative homeostasis, and lack of responsiveness
to TGF-β antimitogenic effects is a hallmark of cancer
(Siegel and Massague, 2003). How cells escape from
TGF-β cytostasis is unknown; genetic studies in pan-
creatic and colorectal cancers pinpoint that a blunted
Smad4 function is a main tool used by tumor cells to
disable this antiproliferative response (Takaku et al.,
1999; Woodford-Richens et al., 2001; Xu and Attisano,
2000). Since Smad4 or other TGF-β pathway compo-
nents are rarely directly inactivated by mutations, alter-
ations in unknown Smad regulators could account for
loss of TGF-β responsiveness in the majority of tumors
(Siegel and Massague, 2003).
Here we describe the identification by functional ex-
pression cloning of Ectodermin (Ecto), a RING-type
ubiquitin ligase for Smad4 that controls TGF-β/BMP re-
sponses. In Xenopus embryos, Ectodermin restricts the
mesoderm-inducing activity of TGF-β signals to the
mesoderm and favors neural induction and is therefore
essential for the specification of the ectoderm germ
layer. The function of Ectodermin is not restricted to
early embryogenesis; it is expressed in human adult
cells, where it is an intrinsic limiting factor for TGF-β/
Smad4-induced cytostasis. We argue that Ectodermin
is a potent endogenous negative regulator of Smad re-
sponses in vertebrate cells.
Cell
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(Figure 1. Functional Cloning of Ectodermin, a Maternal Determinant
Regulating Cell Fates in Early Xenopus Embryos c
f(A) Current model for the induction of primitive germ layers in Xeno-
Epus embryos.
s(B) Functional cloning strategy for candidate ectoderm determi-
(nants.
s(C) Schematic representation of the Ectodermin protein. The linkerinal TRIM domain composed of a RING finger, two B
equence is unique to Xenopus and mammalian Ectodermin (Ecto).
omains at the N terminus (RING finger, B boxes, coiled coil) and
he C terminus (PHD, bromodomain) are shared with other mem-
ers of the Tif1/TRIM protein family.
D–F) Expression analysis of Ectodermin by in situ hybridization.
rrowhead in (F) points to the dorsal lip. Embryos shown in (E) and
F) were bisected before in situ hybridization to allow penetration
f the probe in the more vegetal regions. Controls for the in situs
re provided in Figure S1.
G and H) Ectodermin protein is a localized determinant in the pros-
ective ectoderm germ layer. (G) shows whole-mount immunolo-
alization of the endogenous Ectodermin protein on bisected blas-
ula-stage embryos. Magnifications showing specific nuclear
taining and additional controls are provided in Figure S1. (H)
hows quantitative analysis of Ectodermin protein distribution
long the animal-vegetal axis. Anti-Ectodermin immunoblot shows
igh enrichment of Ectodermin protein in explanted animal cells
An), low expression in marginal explants (MZ), and no expression
n vegetal base (Vg), all explanted from blastula-stage embryos.
ibling explants were pretested by RT-PCR to verify their identity
ccording to molecular markers.
I–N) Molecular characterization of the biological activity of Ecto-
ermin by in situ hybridization. Sox2 is an ectoderm and neural
late marker; Xbra and Mix.1 are mesoderm markers. (I and J) Em-
ryos at the four-cell stage were radially injected with Ecto mRNA
350 pg/blastomere) and harvested at the early gastrula stage
stage 10+). (K–N) Eight-cell-stage embryos were injected with Ecto
RNA (1 ng) in a single blastomere (marginal zone), together with
acZ mRNA (200 pg), to identify injected cells (in red). Embryos
ere harvested at the gastrula stage (stage 11).
O) RT-PCR analysis of marginal-zone explants (VMZ) expressing
ontrol (GFP mRNA, 1 ng) and Ecto mRNA (1 ng). Cells normally
ated to express mesendoderm markers (Mix.2, Vent-1, Xwnt8,
omes, Xbra) now change their fate, upregulating the ectoderm-
pecific marker Sox2.
P and Q) Long-term phenotypic effects of Ecto mRNA overexpres-
ion. Arrowheads indicate ruffled ventral epidermis.esults
unctional Expression Cloning of Ectodermin,
Maternal Determinant Promoting
ctoderm Development
e used an unbiased screening strategy to identify
olecules involved in the specification of the embry-
nic ectoderm. To do this, we searched for genes that,
nce overexpressed in Xenopus embryos, could trans-
orm mesoderm cells into ectoderm precursors. The
ationale of this approach relies on embryological ob-
ervations indicating that, by the blastula stage, un-
dentified ectodermal determinants are located in the
mbryo’s animal hemisphere and can direct the differ-
ntiation of ectoderm derivatives (Wessely and De Rob-
rtis, 2000; Zhang et al., 1998) (Figure 1A).
We cloned a blastula-stage cDNA library into an RNA
xpression plasmid. Synthetic mRNA was prepared
rom pools of 50 clones and injected in the equatorial
egion of four-cell-stage embryos, that is, in the pros-
ective mesoderm (Figure 1B). Injected embryos were
ssayed by in situ hybridization at the early gastrula
tage for reduction of the mesoderm marker Xbra and
xpansion of the early ectoderm marker Sox2 (Mizuseki
t al., 1998).
One positive pool was sib selected, and the isolated
DNA corresponded to a new Xenopus ORF named Ec-
odermin (Ecto). The Ectodermin protein has an N-ter-
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89boxes, and a coiled coil, followed by a central linker
region of unique sequence and a C-terminal PHD/bro-
modomain (Figure 1C). Ectodermin is the homolog of a
mammalian gene with unknown functions, cited in the
literature with different names, TRIM33, Tif1γ, Ret-fused
gene 7, and PTC7 (Venturini et al., 1999); for clarity, we
refer to it herein as human Ectodermin (hEcto), as we
found that it shares similar functions and comparable
biochemical activities with Xenopus Ectodermin.
We then determined the expression pattern of Ecto-
dermin during Xenopus development by in situ hybrid-
ization and immunohistochemistry. Ectodermin RNA is
present in the animal pole of unfertilized eggs and
throughout cleavage stages (Figure 1D and data not
shown). At the blastula stage, Ectodermin mRNA and
protein are localized in the animal pole, extending, at
lower levels, up to the marginal zone (Figures 1E, 1G,
and 1H; see also Figure S1). At the onset of gastrula-
tion, Ectodermin RNA level has already dramatically
declined, but, intriguingly, it remains asymmetrically en-
riched in the dorsal side of the early gastrula (Figure
1F). As gastrulation proceeds, Ectodermin expression
progressively fades.
To test the biological activity of Ectodermin in more
detail, we injected Ecto mRNA in Xenopus embryos. As
shown in Figures 1I and 1J, forced expression of Ecto
mRNA leads to an expansion of Sox2 into the pros-
pective mesoderm; concomitantly, expressions of Xbra,
Eomes, and Vent-1, as well as of the mesendoderm
markers Mix.1 and Mixer, are downregulated in injected
cells (Figures 1K–1N and data not shown). RT-PCR
analysis of explanted ventral marginal zones (VMZ) in-
dicates that misexpression of Ectodermin can change
the fate of mesoderm precursors into ectoderm (Figure
1O). In agreement with such molecular characteriza-
tion, overexpression of Ectodermin has powerful long-
term phenotypic effects. Embryos were injected at the
two-cell stage in the marginal zone with 1 ng of Ecto
mRNA and then monitored for appearance of morpho-
logical defects. Despite cleaving normally, part of the
Ecto mRNA-injected embryos (n = 275, 33%) failed to
complete gastrulation (data not shown). The surviving
embryos displayed severe defects (93%), including
shortened axis, head reduction, and a ventral cyst of
an extensively folded epidermis (Figures 1P and 1Q). In
sum, Ectodermin is a molecule endowed with powerful
biological activity that promotes ectoderm develop-
ment at the expense of other germ layers.
Ectodermin Regulates Germ-Layer Identity
along the Animal-Vegetal Axis
The functional cloning, expression pattern, and biologi-
cal activity of Ectodermin make it an attractive candi-
date as an endogenous ectoderm determinant. As key
test for the developmental relevance of Ectodermin, we
carried out the knockdown of Ecto by targeting its ex-
pression with a morpholino oligonucleotide (Ecto-MO)
designed to cover the initial codons of Ectodermin
mRNA. As specificity control, we used a mutant version
of the same morpholino (control-MO). Ecto-MO was
specifically effective in reducing the level of endoge-nous Ectodermin protein in morpholino-injected em-
bryos (“Ecto-morphants”) (Figure 2A).
We investigated the molecular effects of Ectodermin
knockdown by monitoring expression of marker genes
in animal cap cells isolated at the late blastula stage.
Control explants never expressed markers of other
germ layers. Remarkably, Ecto-depleted cells displayed
the activation of a mesoderm-specific gene expression
profile, as monitored by Eomes, VegT, and Mix.2 ex-
pression, and the downregulation of the ectoderm
marker Sox2 (Figure 2B and Figure S2A).
Next we tested to what extent Ectodermin is required
for patterning of the whole embryo. Ecto-MO and con-
trol-MO were injected in the prospective marginal zone
of one-cell embryos and were analyzed by whole-
mount in situ hybridization when embryos reached the
gastrula stage. In Ecto-morphants, the mesoderm
marker VegT was upregulated and expanded toward
the animal pole (compare Figures 2C and 2D). Expres-
sion of Mixer, which marks in the endoderm the border
with the adjoining mesoderm, displayed an abnormal
expansion into the prospective mesodermal mantle
(compare Figures 2G and 2H; see also Figure S2B).
Morphologically, Ecto-morphants cleaved normally but
displayed a severely retarded gastrulation; once past
the midgastrula stage, they stopped developing (data
not shown), likely reflecting the changes in cell fate and
motility caused by the aberrant patterning of these em-
bryos. Crucially, expansion of VegT and Mixer is res-
cued by adding back Ectodermin, as achieved by injec-
tion of a morpholino-insensitive Ecto mRNA in the
animal blastomeres of Ecto-morphant embryos (Fig-
ures 2E and 2I). These data support the view that Ecto-
dermin is a critical switch for establishing germ-layer
identity along the animal-vegetal axis of the embryo.
Ectodermin Prevents TGF- Signaling
A wealth of data indicates that the primary mesoderm-
inducing signal in vertebrate embryos is delivered by
growth factors of the TGF-β superfamily (Whitman,
2001). To test whether Ectodermin antagonizes the ac-
tivity of TGF-β ligands, we assayed in animal caps the
effect of increased levels of Ectodermin on the gene
responses triggered by TGF-β signaling (Figure 3A). We
found that coinjection of Ecto mRNA inhibits in a dose-
dependent manner the induction of Xbra and Mixer by
Activin mRNA (Figure 3A, lanes 2–5). Similar results
were obtained with an activated TGF-β receptor (CA-
Alk5) and Smad2 (lanes 6–9). As specificity control,
Xbra induction triggered by overexpression of an active
FGF receptor is not blocked by Ecto mRNA (lanes 10
and 11). Furthermore, human Ectodermin, but not the
related TRIM family member KAP1 (Venturini et al.,
1999), recapitulates the anti-TGF-β activity of Xenopus
Ectodermin (Figure S3).
Since overexpression of Ectodermin inhibited TGF-β
signaling, we tested whether the depletion of Ecto-
dermin enhanced gene responses triggered in vivo by
TGF-β ligands. To do so, we treated animal cap cells
injected with a low dose of Ecto-MO (25 ng) with a sub-
optimal concentration of Activin protein. As shown in
Figure 3B, Ecto knockdown sensitized the response to
Activin. This finding suggests that the expansion of
Cell
90Figure 2. Depletion of Ectodermin Causes a
Shift in Cellular Fates along the Animal-Veg-
etal Axis
(A) Ecto morpholino oligonucleotides speci-
fically knockdown the translation of endoge-
nous Ectodermin protein in whole embryos
(control-MO and Ecto-MO, 60 ng/embryo).
(B) Animal caps were injected with 60 ng of
control-MO or Ecto-MO, explanted at the
late blastula stage (stage 9.5), and analyzed
by RT-PCR. Note the induction of mesoderm
markers in Ecto-depleted cells. (C–J) Molec-
ular characterization of Ecto knockdown by
in situ hybridization on whole embryos (mid-
gastrula stage). (C and D) Zygotic VegT, a
mesoderm-specific marker, spreads toward
the animal pole. (G and H) Mixer expression
at the boundary between endoderm and
mesoderm (dashed line) is expanded. Arrow-
heads point to the dorsal lip. A morpholino-
insensitive Ecto mRNA (1.5 ng) is biologically
active (F and J) and reverses the knockdown
phenotypes (E and I). Targeted injection of
Ecto-MO in marginal explants confirms ec-
topic expression of Mixer and Mix.2 in the
mesoderm (see Figure S2B).mesoderm-specific gene expression observed in whole (
aembryos and explants upon Ectodermin knockdown
(shown in Figure 2) is due to an unrestrained response a
ato endogenous TGF-β/nodal ligands. Consistently, the
induction of mesoderm markers detected by RT-PCR in r
oEcto-MO-injected (60 ng) cells was blocked by coin-
jected Cer-S, an extracellular nodal antagonist (Piccolo C
det al., 1999) (Figure 3C).
s
BEctodermin Attenuates BMP Signaling and Favors
Neural Development d
iWe next tested whether Ectodermin antagonizes BMP
signaling. As shown in Figure 3D, induction of Vent-1 by
cconstitutive-active BMP receptor (CABR) and Smad1
mRNAs is blocked by overexpression of Ectodermin. In m
swhole-embryo assays, while injection of low doses of
Smad1 mRNA produces headless embryos, the coin- f
ejection of Smad1 and Ecto mRNAs rescues normal de-
velopment (Figure S4). In agreement with these obser- t
Tvations, the long-term overexpression of Ectodermin
mRNA in animal cap cells leads to the activation of neu- v
iral markers (Figure 3E).
As Ectodermin is highly expressed in prospective ec- B
toderm cells, these data suggest that Ecto would favor
neural development in vivo by inhibiting BMP signaling. A
WWe first tested this hypothesis in isolated ectoderm ex-
plants. Neural induction was triggered by overexpres- v
Tsion of the BMP antagonist Chordin; notably, in cells
explanted from Ecto-morphant embryos, inductions of T
othe neural markers NCAM and Sox2 were downregu-
lated (Figure 3F, see legend). Next we validated this o
Tconclusion in whole embryos (Figures 3G–3L). Embryos
were injected in the animal hemisphere with Ecto-MO t30 and 60 ng) and control-MO (60 ng) and analyzed in
dvanced neurulae for expression of Sox2 and cytoker-
tin (Ker), which, at this stage, mark the neural plate
nd epidermis, respectively. Injection of Ecto-MO caused
eduction of neural tissue and concomitant expansion
f epidermis despite presence of normal expression of
hordin in Ecto-morphants (data not shown). Thus, re-
uction of Ectodermin levels leads to an attenuated re-
ponse to neural inducers, likely reflecting unrestrained
MP signaling. Accordingly, we found that suboptimal
oses of Ecto and Chordin mRNAs cooperate in neural
nduction (Figure S5).
In vivo, expression of Ectodermin temporally pre-
edes the appearance of neural inducers in the Spe-
ann Organizer (Figure 1). Taken together, the data pre-
ented so far suggest a model for the biological
unction of Ectodermin (Figure 3M): Ectodermin acts in
arly development to protect the primary ectodermal
erritory from mesoderm-inducing signals delivered by
GF-β/nodal cytokines emanating from the embryo’s
egetal hemisphere. Such intrinsic anti-TGF-β-signal-
ng activity also plays a role in preventing an excess of
MP signaling prior to gastrulation.
n Ectodermin-Smad4 Complex
e found that human Ectodermin is expressed in a
ariety of cell lines from adult tissues (data not shown).
o validate the antagonism between Ectodermin and
GF-β signaling in human cells, we assayed the effect
f human Ectodermin on the transcriptional activation
f Smad-dependent enhancers. As direct readout of
GF-β signaling, we used the CAGA12 luciferase syn-
hetic reporter, which is activated by a complex be-
A Smad4-Limiting Factor in Development and Cancer
91Figure 3. Ectodermin Prevents TGF-β and
BMP Signaling
(A) RT-PCR analysis of animal caps express-
ing the indicated mRNAs (dose in parenthe-
sis). Lanes 2–5: the inductions by Activin (40
pg) are downregulated by increasing doses
of Ecto (lane 3, 200 pg; lane 4, 400 pg; lane
5, 800 pg). Lanes 6–11: Ecto (500 pg) blocks
inductions by CA-Alk5 (200 pg) and Smad2
(300 pg) but not by FGFr1 (1 ng).
(B) RT-PCR analysis of injected animal caps
shows that a low dose of Ecto-MO (25 ng),
which is inactive by itself, can induce meso-
derm very effectively in conjunction with
suboptimal doses of Activin protein (com-
pare lane 4 with lanes 2 and 3).
(C) Ectopic mesoderm gene expressions
triggered by Ecto-MO (60 ng) are blocked by
coinjection of the TGF-β antagonist Cer-S
mRNA (300 pg).
(D) Activation of the BMP target Vent-1 by
Smad1 mRNA (1 ng) and CABR mRNA (700
pg) is antagonized by Ecto mRNA (800 pg).
(E) Forced expression of Ecto mRNA (400 pg
and 800 pg) in cultured animal caps (har-
vested at stage 27) leads to upregulation of
neural markers (NCAM and Sox2) and down-
regulation of epidermis (Ker).
(F) Ecto-depleted animal cap cells display a
reduced responsiveness to neural induction
triggered by increasing amounts of Chordin
mRNA. Ecto-depleted animal cap cells are
resistant to weak BMP antagonism (lanes 3
and 4) but still undergo neural default dif-
ferentiation upon complete BMP blockade
(lanes 7 and 8). To prevent any interference
with the mesoderm-inducing effects of Ecto-
MO (+), animal caps were explanted at the
early blastula stage (stage 8–8.5), when they
have not yet received any mesoderm-induc-
ing signal. (−) stands for Control-MO.
(G–L) Downregulation of Ectodermin by
doses of Ecto-MO parallels with reduction of
neural tissue (Sox2) and concomitant expan-
sion of epidermis (ker).
(M) A model for the function of Ectodermin
during embryogenesis.tween Smad3 and Smad4. For BMP signaling, we moni-
tored transcription from the minimal Vent-2 promoter,
whose activation relies on Smad1/Smad4 complexes.
As shown in Figures 4A and 4B, raising the levels of
Ectodermin in human cells inhibits the transcriptional
response to TGF-β/BMP ligands on these reporters.
These studies suggest that Ectodermin operates within
the TGF-β/BMP signaling cascades.
We investigated whether the biological antagonism
between Ectodermin and TGF-β signals reflected a
physical interaction between Ectodermin and the Smads.
Indeed, coimmunoprecipitation experiments using epi-
tope-tagged proteins from HEK293T cells showed that
Ectodermin binds Smad4 but not other Smads (Figure
4C). To determine whether this interaction occurred at
physiological protein levels, we immunoprecipitated
endogenous Ectodermin from HEK293T cells and moni-
tored for copurified Smad4 by Western blot and vice-
versa. As shown in Figures 4D and 4E, Ectodermin and
Smad4 form a complex in vivo. By using a GST-Smad4
affinity matrix and in vitro-translated Ectodermin frag-ments, we mapped the interaction domain with Smad4
in the linker region of Ectodermin (Figure 4F). Notably,
the Ectodermin/Smad4 biochemical interaction is con-
sistent with the biological effects of Ectodermin, being
that Smad4 is shared by the BMP and TGF-β signal-
ing branches.
Next we tested whether the antagonism between Ec-
todermin and TGF-β/BMP signals is mediated by its
specific interaction with Smad4. As shown in Figure 4G,
expression of Smad4 rescues the activation of neural
markers by injected Ecto mRNA (lanes 2–4). Con-
versely, expression of Ectodermin counterbalances
mesoderm expansion by increased Smad4 levels, as
attained by mRNA injection in the marginal zone of the
embryo (Figure 4H). Previous work has shown that ec-
topic expression of Smad4 in animal cap cells is a quite
inefficient inducer of mesoderm (Howell et al., 1999);
given the high level of Ectodermin expression in the
animal cap, we speculated this may account, at least
in part, for the low efficacy of Smad4 in this tissue. Ac-
cordingly, we found that partial depletion of Ectodermin
Cell
92Figure 4. Ectodermin Binds Smad4
(A) Human Ectodermin inhibits TGF-β signal-
ing. The CAGA12 luciferase reporter (100 ng)
was transfected in HEK293T cells alone or in
combination with human Ectodermin ex-
pression plasmid (500 ng) as indicated. After
transfection, cells were either left untreated
(white bars) or treated with 100 pM TGF-β1
(black bars). Doses are for transfection of 2
cm2 wells. Error bars are standard devia-
tions.
(B) Human Ectodermin inhibits BMP signal-
ing. The Vent-2 BMP minimal responsive ele-
ment (150 ng) was transfected in HepG2
cells alone or in combination with human Ec-
todermin expression plasmid (500 ng) as in-
dicated. BMP signaling was provided by co-
transfected CA-Alk3 and Smad1 expression
plasmids.
(C) Ectodermin interacts with Smad4 in vivo.
Shown is immunoprecipitation (anti-HA anti-
body) of HEK293T cell lysates transfected
with the indicated expression plasmids for
different Flag-tagged Smad proteins and
HA-tagged Xenopus Ecto.
(D and E) A physiological complex between
endogenous Ectodermin and Smad4 in
HEK293T cells. pep indicates the Ectoder-
min immunogenic peptide competing for
the antibody.
(F) In vitro interaction between Ectodermin
deletion mutants and Smad4. In vitro-trans-
lated 35S-Ecto fragments were incubated
with bacterially expressed Smad4 as Seph-
arose bound GST fusion. Copurifying Ecto
fragments were resolved by SDS-PAGE and
visualized by autoradiography. The linker re-
gion of Ectodermin contains the Smad4 in-
teraction domain.
(G) RT-PCR analysis of cultured animal caps
(harvested at stage 27) expressing the indi-
cated mRNAs (dose in parenthesis). Lanes
2–4: the neural markers’ inductions (Sox2
and NCAM) by Ecto (400 pg) are downregu-
lated by increasing doses of Smad4 (lane 3,
3 ng; lane 4, 6 ng).
(H) In situ hybridization for the mesoderm
marker VegT on embryos uninjected (control)
or injected in a single blastomere at the four-
cell stage with Smad4 mRNA (2.5 ng) alone
or in combination with Ecto mRNA (800 pg).
Pictures are lateral close-up views, with
blastopore lip at the bottom. Dashed line in-
dicates the normal upper limit of VegT ex-
pression.enables mesoderm induction by doses of Smad4 w
EmRNA that are otherwise inactive (Figure S6).
Two different Smad4s have been described in Xeno- m
hpus: XSmad4α is the homolog of mammalian Smad4;
the second Smad4 (XSmad4β) displays mesoderm- f
ainducing abilities as well as additional TGF-β/BMP-
independent effects during neural development (Howell i
cet al., 1999; LeSueur et al., 2002). Coinjection of Ecto
mRNA inhibits mesoderm induction triggered in animal t
wcaps by both XSmad4 mRNAs (Figure S7).
a
pEctodermin Ubiquitinates Smad4
Ectodermin might antagonize Smad4 by any of several S
mechanisms. One possibility that retained our attentionas that Ecto might affect Smad4 stability, given that
ctodermin contains an N-terminal RING finger, a do-
ain found in several E3 ubiquitin ligases. To test this
ypothesis, we prepared a point mutation in the RING-
inger domain of Ectodermin, creating a catalytically in-
ctive mutant, Ecto-CAmut (C97A/C100A). This mutant
s unable to interact within the ubiquitination ma-
hinery, resulting in a protein void of any E3 ligase ac-
ivity (Zhu et al., 1999). Importantly, when compared to
ild-type Ectodermin, Ecto-CAmut was biologically in-
ctive in frog assays (Figure 5A). Of note, Ecto-CAmut
rotein retains normal Smad4 binding capability (Figure
8). These results argue that the biological activity ofEctodermin as TGF-β antagonist primarily stems from
A Smad4-Limiting Factor in Development and Cancer
93the enzymatic activity of its RING finger rather than
from other mechanisms, i.e., Smad4 sequestration.
The potential for Ectodermin to modulate the stability
of Smad4 was tested in Xenopus cells. In the presence
of coexpressed Ectodermin, the steady-state levels of
Smad4 were severely decreased (Figure 5B, lanes 5
and 6), whereas Ectodermin had no effect on the
steady-state levels of Smad2 or Smad3 (Figure 5B,
lanes 1–4). To investigate whether Ectodermin pro-
motes Smad4 degradation, we analyzed the turnover
of overexpressed Smad4 by pulse-chase experiments
in human HEK293T cells. Figure 5C shows that, al-
though the level of newly synthesized Smad4 is similar
in all samples, with increasing incubation times the dis-
appearance of Smad4 was accelerated in cells trans-
fected with human or Xenopus Ectodermin expression
plasmids. Overexpression of Ectodermin leads also to
decreased steady-state levels of endogenous Smad4
(Figure 5D, lanes 1–3), an effect reversed by treatment
of transfected cells with MG132, an inhibitor of the 26S
proteasome (Figure 5D, lanes 4–6). Together, these data
indicate that Ectodermin enhances Smad4 degradation
via the ubiquitin-proteasome pathway.
Next we tested whether Ectodermin operates as a
Smad4 ubiquitin ligase. As shown in Figure 5E, combi-
nations of ubiquitin, Smad4, and Ecto expression con-
structs were transfected in HEK293T cells. We moni-
tored the in vivo formation of ubiquitin-conjugated
products of Smad4 by assaying immunopurified Smad4
with anti-Smad4 immunoblots. We found that Ecto-
dermin markedly increased ubiquitin-conjugated Smad4,
as demonstrated by migration of Smad4 as a ladder of
high-molecular-weight bands (Figure 5E, compare
lanes 3 and 6), which correspond to ubiquitin-conju-
gated products (data not shown). As a negative control,
the RING-finger mutant hEcto-CAmut (C125A/C128A)
was not effective in this assay (Figure 5F).
To test the in vivo relevance of Ectodermin in the pro-
cess of Smad4 ubiquitination, we compared the ubiqui-
tination pattern of Smad4 in wild-type and Ecto-
MO-injected frog embryos. As shown in Figure 5G, the
endogenous machinery ubiquitinating Smad4 is well
active in Xenopus embryos; however, Smad4 ubiquiti-
nation is dramatically reduced upon Ectodermin knock-
down. Similarly, targeting translation of human Ecto-
dermin in HEK293T cells by transfection of morpholino
antisense oligonucleotides inhibited the basal level
of Smad4 ubiquitination (Figure S9). These findings
prompted us to further test the relevance of Ectodermin
on Smad4 stability in Xenopus embryos: as shown in
Figure 5H, depletion of Ectodermin increases the
steady-state levels of injected Myc-tagged XSmad4α.
Together these results suggest that Ectodermin is an
essential mediator of Smad4 ubiquitination and stability
in vertebrate cells.
As originally proposed by Attisano and colleagues,
several Smad4 mutant alleles found in human cancers
code for proteins that become heavily ubiquitinated
and whose instability undermines the tumor-suppres-
sive properties of Smad4 (Xu and Attisano, 2000). We
sought to determine whether endogenous Ectodermin
plays a role in these events. For this, we transfected
the unstable Smad4(R100T) mutant in HEK293T cells
together with control or anti-Ecto morpholinos. Down-
regulation of endogenous Ectodermin protein reflecteda concomitant rise of Smad4(R100T) to levels compara-
ble to those obtained by treatment with the proteasome
inhibitor MG132 (Figure 5I). This finding raises the inter-
esting possibility that, during tumor progression, Ecto-
dermin may cooperate with Smad4 mutations to atten-
uate TGF-β responsiveness in cancer cells.
Ectodermin Antagonizes Nuclear
Accumulation of Smad4
We found that Ectodermin is an exclusive nuclear pro-
tein (Figure 1G and Figures S1E and S10), whereas
Smad4 constantly shuttles in and out of the nucleus
(Nicolas and Hill, 2003). Evidence indicates that this as-
pect of Smad4 regulation is intimately connected to
Smad4 ubiquitination. For instance, ubiquitinated Smad4
mutant proteins found in human cancers are defective
in nuclear accumulation (Moren et al., 2000). Moreover,
sumoylation, a treatment that antagonizes ubiquitina-
tion, promotes Smad4 nuclear accumulation and meta-
bolic stability (Lin et al., 2003). Given these precedents,
we investigated whether Ectodermin regulates the
nuclear versus cytoplasmic localization of Smad4. To
do so, we verified the localization of endogenous
Smad4 in HeLa cells transfected with control-siRNA or
with Ecto-siRNA. In the absence of TGF-β stimulation
(Figure 6A), Smad4 was typically evenly distributed in
nucleus and cytoplasm and found mostly nuclear only
in a minority of cells, as previously reported (Lin et al.,
2003). As expected, treatment with TGF-β shifted part
of the cytoplasmic pool of Smad4 within nuclei (Figure
6B). Remarkably, however, the number of untreated
cells with predominantly nuclear Smad4 increased
markedly upon Ecto depletion, and TGF-β further en-
hanced this phenomenon (Figures 6C and 6D, quantita-
tions in Figure 6F). The results suggest that a physio-
logical function of Ectodermin is to enforce the nuclear
clearance of Smad4.
Ectodermin Restrains TGF--Induced Cytostasis
By setting an attenuated Smad response, Ectodermin
might favor an escape from TGF-β antiproliferative ef-
fects. To test this hypothesis, we used BrdU incorpora-
tion to assay DNA synthesis/cell cycle progression in
control- and Ecto-siRNA-treated HepG2 cells. Deple-
tion of Ectodermin inhibited the basal rate of BrdU in-
corporation and potently enhanced growth arrest in-
duced by exogenous Activin (Figure 6G).
To investigate molecularly the relevance of Ecto-
dermin on the regulation of cell growth, we monitored
the protein levels of the CDK inhibitor p21WAF1, a pivotal
target of TGF-β-mediated tumor suppression (Siegel
and Massague, 2003). Treatment with Ecto-siRNA up-
regulated the basal levels and dramatically enhanced
the induced levels of p21WAF1 as a response to Activin
(Figure 6H). Together, these loss-of-function studies
support the view that Ectodermin has growth-promot-
ing functions in mammalian cells by relaxing the re-
straints on cell proliferation imposed by TGF-β. Of note,
these data remarkably recapitulate the enhanced sensi-
tivity to TGF-β signals previously observed in Ecto-
depleted Xenopus cells.
Cell
94Figure 5. Ectodermin is a Ubiquitin Ligase for Smad4
(A) The biological activity of Ectodermin relies on an enzymatically active RING finger. Two-cell-stage embryos were injected in the marginal
zone with mRNAs (800 pg) encoding wild-type or RING-finger point mutant (EctoCAmut) Ecto proteins and processed by in situ hybridization
for paraxial mesoderm marker MyoD. On the right is Western blotting of embryo lysates showing similar protein levels.
(B) Expression of Ectodermin decreases the steady-state level of Smad4 via the proteasome pathway. Xenopus embryos were radially injected
with 200 pg mRNAs coding for Flag-tagged Smads together with 1 ng of mRNAs for β-gal (−) or xEcto (+). Steady-state protein levels were
determined by Western blotting of total embryo lysates. Lanes 7 and 8: mRNAs were coinjected with the proteasome inhibitor MG132 (10
M/embryo volume). Note that the inhibition of proteasome reverts the effect of Ectodermin on Smad4.
(C) Overexpression of Ectodermin causes an increased rate of Smad4 protein degradation. HEK293T cells were transfected with HA-tagged
Smad4 expression plasmid alone (1 g/10 cm dish) or in combination with human or Xenopus Ectodermin vectors (10 g). After labeling with
35S-Met/Cys and chasing for the indicated times, cell lysates were immunoprecipitated with anti-HA antibody and labeled proteins were
resolved by SDS-PAGE and visualized by autoradiography.
(D) Endogenous Smad4 protein is downregulated by raising the level of Ectodermin in human cells. HEK293T cells were transfected with
pCS2-hEcto (lanes 2 and 5: 7 g; lanes 3 and 6: 20 g) and treated for 6 hr with vehicle (DMSO, lanes 1–3) or 30 M MG132 (lanes 4–6), and
Smad4 steady-state levels were determined by Western blotting. Note that downregulation of Smad4 by hEcto (compare lanes 1–3) is inhibited
in lanes 5 and 6.
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(E) Ectodermin enhances ubiquitination of Smad4. HEK293T cells were transfected with combinations of pCS2-HA-ubiquitin (1 g), pCDNA-
Smad4 (1 g), and pCS2-hEcto (15 g). Cells were harvested after overnight treatment with 10 M MG132, and lysates were boiled in 1%
SDS before immunoprecipitation with anti-Smad4 polyclonal antibody in 0.1% SDS. Ubiquitin-conjugated Smad4 [(Ub)n-Smad4] was detected
by Western blotting with anti-Smad4 monoclonal antibody. The panel is composed by three parts (>120 KDa, 84–120 KDa, and free Smad4
at the bottom) corresponding to different exposition times. Plasmid doses are for transfection of 10 cm petri dish.
(F) Ectodermin ubiquitin ligase activity depends on a catalytically active RING finger. Experimental settings were as described in (E).
(G) The endogenous machinery that ubiquitinates Smad4 in Xenopus relies on Ectodermin. Two-cell-stage embryos were injected with the
indicated combinations of morpholinos (60 ng) and mRNAs (HA-ubiquitin, 1 ng; Flag-Smad4, 1 ng) and harvested at the gastrula stage for
immunoprecipitation with anti-Flag antibody. Ubiquitin-conjugated Smad4 [(Ub)n-Smad4] was detected by Western blotting with anti-HA
antibody (upper IP panel). Equal levels of precipitated free Smad4 were checked by anti-Flag immunoblotting (lower IP panel). At the bottom,
anti-Ecto and anti-actin Western blots of total lysates used for IPs in lanes 3 and 4.
(H) Depletion of Ectodermin increases the steady-state levels of injected XSmad4α in Xenopus embryos. Increasing doses of Myc-tagged
XSmad4α mRNA were coinjected with 50 ng of control-MO (−) or Ecto-MO (+). Embryos were harvested at the gastrula stage for Western
blotting. Epitope-tagged Smad4 was used because antibodies against Xenopus Smad4 are not available.
(I) Ectodermin knockdown in human cells rescues the stability of cancer-derived mutant Smad4(R100T). HEK293T cells were transfected with
Flag-tagged Smad4(R100T) expression plasmid (4 g/10 cm dish) and treated as follows. Lane 1: cotransfection of control-MO; lane 2:
cotransfection of hEcto-MO; lanes 3 and 4: treatment with vehicle (DMSO) or MG132. Western blotting of total cell lysates shows that
depletion of Ecto, just like inhibition of the proteasome, raises Smad4(R100T) level.Smad4 Is Epistatic to Ectodermin
in Regulating Cell Proliferation
A wealth of genetic studies link the inactivation of
Smad4 to the escape from TGF-β/BMP growth-inhibi-
tory responses in several malignancies, especially
those of the pancreas and colon (Howe et al., 1998;
Takaku et al., 1999). As Ectodermin is a regulator of
Smad4 function, we determined the expression of Ec-Figure 6. Ectodermin Limits Smad4 Nuclear
Accumulation and TGF-β-Induced Growth
Arrest
(A–D) Immunofluorescence localization of
endogenous Smad4 in control-siRNA- and
Ecto-siRNA-depleted HeLa cells, untreated
or treated for 90 min with 5 ng/ml TGF-β1
(see Experimental Procedures). Nuclei of
the same cells were stained with Hoechst
(A#–D#).
(E) Western blotting for samples shown in
(A)–(D) to demonstrate quantitative depletion
of endogenous Ecto by RNAi.
(F) Quantitations of HeLa cells displaying
nuclear Smad4 (same as pictures shown in
[A]–[D]). (A) 18%, n = 266; (B) 46%, n = 536;
(C) 49%, n = 305; (D) 79%, n = 965. Error
bars are standard deviations.
(G) Growth-inhibitory effect of Activin on
mock and Ecto-siRNA-treated HepG2 cells,
as measured by BrdU incorporation. Col-
umns show the percentage of cells in active
DNA synthesis. Inset: the number of BrdU-
positive cells in unstimulated cultures was
given an arbitrary value of 100%; all other
values (Activin treatments) are shown rela-
tive to this. Activin is more effective upon
Ecto knockdown.
(H) Time course of p21WAF1 induction by Ac-
tivin (20 ng/ml) in mock and Ecto-depleted
HepG2 cells. t = 0 is 48 hr after transfection
of siRNA. Note that induction of p21WAF1 has
an earlier onset and reaches higher levels
upon Ecto knockdown.tine. Strikingly, Ectodermin is localized in the nuclei of
the stem cells at the bottom of the crypts (i.e., prolifera-
tive compartment) (Figures 7A and 7C), and this stain-
ing declines in the higher portion of the gland, becom-
ing undetectable in the superficial (i.e. differentiated)
compartment (Figure 7B) (n = 8, 100%; normal mucosa
obtained from the right colon). It has been proposed
that the biology of intestinal tumors closely recapitu-
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96Figure 7. Ectodermin Controls Cell Proliferation via Smad4
(A–E) Immunohistochemical nuclear expression of Ectodermin in normal (A–C) and neoplastic (D, adenomas; E, carcinomas) human colon.
(F and G) Effects of Ectodermin depletion on cell proliferation as measured by BrdU incorporation. Green is anti-BrdU; blue is Hoechst. (G)
Smad4 is epistatic to Ectodermin. Columns show the effect of Ecto-siRNA depletion on cell proliferation (black bars) relative to control-
siRNA-treated cultures (gray bars). The immunoblot lanes on the top confirm the quantitative knockdown of Ecto in each cell line. Only cells
wild-type for Smad4, but not Smad4-null cells, are growth arrested upon Ecto downregulation.
(H) Depletion of Ecto partially rescues the TGF-β1 (5 ng/ml) growth-suppressing activity in C32 cells. Inset: anti-phospho-Smad2 immunoblot
shows that TGF-β1 signaling is effective in C32 cells.progenitor stem cells (van de Wetering et al., 2002). Ac- e
Rcording to this hypothesis, the immunohistochemical
expression of Ectodermin was tested in a pilot series of s
7eight cases of advanced colonic precancerous lesions
(adenomas with low- and high-grade dysplasia) and in c
Sfour fully developed, well-differentiated, epithelial co-
lonic malignancies. A noncompartmentalized overex- (
qpression of Ectodermin was found in all cases of both
colonic adenomas and adenocarcinoma (Figures 7D c
Mand 7E).
Next we sought to determine whether Ectodermin c
oplays a causative role in proliferation of colorectal can-
cer (CRC) and breast cancer cells by keeping blunted S
wSmad4-dependent growth inhibition. We used C32 cells
as a CRC model system, as these cells express high A
samounts of Ectodermin and display an attenuated
TGF-β-induced growth inhibition (Figure 7H), despite mxpression of wild-type Smad4 protein (Woodford-
ichens et al., 2001) and capacity to transduce TGF-β
ignals (see the phospho-Smad2 immunoblot in Figure
H). In parallel, we also used the MDA-MB231 breast
ancer cell line, which retains low levels of wild-type
mad4 and displays attenuated TGF-β responses
Chen et al., 2001). As shown in Figure 7F, transient but
uantitative depletion of Ectodermin by RNAi drasti-
ally inhibited cell proliferation in both C32 and MDA-
B231 cells, as assayed by BrdU incorporation. Cru-
ially, this inhibition operates via Smad4, as depletion
f Ectodermin in Smad4 mutant cells (colon HT29,
W620, and HT55, and breast MDA-MB468 cell lines)
as void of any effect on cell proliferation (Figure 7G).
s Smad4 appears epistatic to Ectodermin, this finding
trengthens the notion that Smad4 regulation is the pri-
ary biological target of Ectodermin. Interestingly, in
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of TGF-β1-induced growth arrest (Figure 7H). Collec-
tively, the results suggest that Ectodermin is critical for
the control of cell proliferation in some human cancers.
Discussion
An Ectoderm Determinant in Xenopus Embryos
We identified Ectodermin (Ecto) in an unbiased screen
for regulators of early embryonic development. Ecto-
dermin is a localized factor essential for correct forma-
tion of the embryonic germ layers. Depletion of Ecto-
dermin from the marginal zone of the embryo causes a
shift in the cellular fates along the animal-vegetal axis.
The endoderm is expanded well within the prospective
mesoderm, whereas the mesoderm, which normally en-
tails a ring of cells at the equator of the embryo, now
spreads toward the animal pole at the expense of the
ectoderm. Such loss-of-function phenotype of Ecto-
dermin is recapitulated by overexpression of Smad4 in
the marginal zone, in agreement with the identification
of Smad4 as the main target of Ectodermin. This indi-
cates that, by keeping TGF-β/nodal signaling under
control, Ectodermin ensures that ectoderm cells do not
adopt a mesodermal fate. Thus, the early frog embryo
is patterned by two maternal factors located at the an-
tipodes of the egg: Ectodermin at the animal pole and
VegT at the vegetal pole (Zhang et al., 1998). The fine
balance between these opposite activities regulates
the correct allocation of cells to the primary germ layers
(Figure 3M).
In contrast to mesoderm, ectoderm can form in the
absence of cell-cell contact, differentiating as neural
tissue whenever BMP ligands are antagonized (Piccolo
et al., 1996; Wilson and Hemmati-Brivanlou, 1995; Zim-
merman et al., 1996); this suggests that maternal, cell-
autonomous factors do exist to favor the default neural
fate. Knockdown of Ectodermin impairs neural induc-
tion triggered by BMP inhibition; conversely, raising the
level of Ecto causes expression of neural markers in
animal cap cells, and adding back Smad4 reverses
these inductions. Thus, Ectodermin generates a bias
toward neural differentiation. The need for a control
over BMP signaling in the differentiating ectoderm is
not unprecedented since other TGF-β-negative regula-
tors expressed in this tissue have been described, such
as Smurf-1, the E3 ubiquitin ligase for Smad1, the
secreted factor Coco, and the BMP decoy receptor
BAMBI (Bell et al., 2003; Onichtchouk et al., 1999; Zhu
et al., 1999). Indeed, BMP signaling is capable of an
efficient feed-forward loop, with BMP fostering its own
expression (Schmidt et al., 1996), raising the need for
multiple inhibitory control mechanisms to ensure its
strict spatial and temporal control in early embryos, at
least until the Organizer’s antagonists ensure a BMP-
free zone in dorsal ectoderm.
Ectodermin Limits Smad4 Function
Although Smad4 plays a fundamental role in TGF-β sig-
naling during development, homeostasis, and cancer,
our knowledge on its regulation remains limited (Siegel
and Massague, 2003). Recent evidence, however, hashighlighted a central role for Smad4 ubiquitination (Lin
et al., 2003; Moren et al., 2000; Xu and Attisano, 2000).
Yet the molecular effectors of this activity remain enig-
matic. Ectodermin binds Smad4 at the endogenous
protein level and is required for Smad4 ubiquitination in
vivo. In so doing, Ectodermin promotes Smad4 meta-
bolic instability by increased proteasomal degradation.
Our findings suggest a model in which Ectodermin con-
strains TGF-β/BMP gene responses by promoting
Smad4 ubiquitination in the nucleus and favoring
Smad4 relocalization in the cytoplasm, where it can be
efficiently degraded. In support of this notion, Ecto-
depleted cells display an increased nuclear accumula-
tion of Smad4.
One intriguing possibility is that, in some cellular
contexts, Ectodermin may mostly promote nuclear ex-
clusion of Smad4 rather than its degradation. This
would represent an economic but nevertheless effec-
tive mechanism to make cells transiently incompetent
to activate TGF-β gene responses, without depleting
cells of a key tumor suppressor. In other cases, espe-
cially in cancers, Ectodermin may also favor Smad4
degradation, leading to a more stable escape from the
TGF-β antiproliferative response.
Ectodermin Is a Determinant for Cell Proliferation
We found that Ectodermin is an endogenous limiting
factor for cytostasis induced by TGF-β/Smad4 signal-
ing in human cells. When Ecto is disabled by RNAi,
cells respond more potently to TGF-β signals, display-
ing a marked exit from the cell cycle. It has been shown
that the activation of the CDK inhibitor p21WAF1 is
central in TGF-β-induced cytostasis and requires per-
sistent Smad accumulation in the nucleus (Nicolas and
Hill, 2003). Notably, in Ecto-depleted cells, p21WAF1 is
promptly activated by TGF-β signals without delay;
also, p21WAF1 is now induced at much higher levels
than in control cultures. Such robust antiproliferative ef-
fects and endogenous gene responses indicate that
Ectodermin acts as a rate-limiting step for TGF-β sig-
naling.
During normal tissue homeostasis, escape from
TGF-β/Smad4-induced cytostasis is crucial in a subset
of progenitor cells devoted to ensuring epithelial re-
newal (Howe et al., 1998; Siegel and Massague, 2003).
In the colon, these stem cells lie at the bottom of the
intestinal crypts (Bienz and Clevers, 2000). Intriguingly,
we have shown that Ectodermin is expressed in these
cells and is downregulated as cells enter the differentia-
tion compartment. This finding suggests that Ecto-
dermin may behave as a switch, limiting TGF-β/BMP
signaling in normal crypt progenitors and being turned
off as cells need to exit from the cell cycle and dif-
ferentiate.
Lack of responsiveness to TGF-β antiproliferative ef-
fects is a hallmark of cancer. Yet cancer cells specifi-
cally disable the antimitogenic effects and remain free
to exploit with impunity other TGF-β responses to fos-
ter their own growth or malignant behavior (Derynck et
al., 2001). As for the relevance of Smad4 in these pro-
cesses, genetic data indicate that loss of Smad4 may
Cell
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acytostatic response but also with the acquisition of an
invasive phenotype (Takaku et al., 1998). Notably, we
found that depletion of Ectodermin is by itself sufficient S
to trigger growth inhibition in colorectal and breast can- S
cer cell lines, despite the presence of multiple onco- a
wgenic mutations in these cells. Crucially, this depends
on the presence of wild-type Smad4, as quantitative
depletion of Ectodermin is void of any effect in Smad4- A
null cell lines. Given that the majority of tumors do re-
tain wild-type Smad4, it will be interesting to test W
whether functional inactivation of Smad4 promoted by C
REctodermin would not only favor proliferation but also
Uunleash the transforming potential of TGF-β. Whether
tthe interference with Smad4 ubiquitination or Ecto-
c
dermin-Smad4 protein-protein interaction might repre- f
sent a novel therapeutic strategy remains to be investi- a
gated. m
M
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Experimental Procedures w
C
cDNA Library Construction, Functional Screen, #
and Biological Assays in Xenopus I
A full-length enriched cDNA library (3.5 kb average size) cloned in
a pCS2-derivative plasmid (Cordenonsi et al., 2003) was prepared
R
from Xenopus blastulae and contained 40,000 primary trans-
R
formants. A total of 7500 primary clones were assayed as de-
A
scribed in the text. Xenopus embryo manipulations, in situ hybrid-
P
ization, and capped mRNA preparation were as in Piccolo et al.
(Piccolo et al., 1999). RT-PCR primers and cycling conditions are R
described in http://www.hhmi.ucla.edu/derobertis/, except in ex-
periments entailing control-MO/Ecto-MO injections in animal caps
B
for mesoderm induction assays (VegT, Eomes, and Mix.2 markers),
l
for which we added two cycles to each sample.
a
The morpholino antisense oligonucleotide (GeneTools) directed
1
against Xenopus Ectodermin (Ecto-MO) was CACCTCCTCCTTTGT
BTATCCGCCAT, and its mismatching control (control-MO) was
sCAGCTCCTGCTTTCTGATGCGCGAT.
C
o
Cell Culture and Transfections in Mammalian Cells f
See Supplemental Data for technical details. For experiments en- A
tailing morpholino-mediated knockdown, HEK293T cells were first C
transfected with expression plasmids as above and 24 hr later a
treated twice with control or hEcto morpholino/EPEI complexes r
(GeneTools) in Optimem (Gibco), as detailed by GeneTools. Se- C
quence of hEcto-MO was CCGCCGCCTTTGTTTTCCGCCATGT.
D
For siRNA treatments, cells were plated onto collagen I-coated
(
dishes to avoid clumping. dsRNA oligos (Ambion, 75 ng/cm2) were
o
transfected twice using the Oligofectamine protocol (Invitrogen),
Dwith the second transfection performed 24 hr after the first one.
iControl-siRNA was the unrelated sequence 5#-UUCUCCGAACGU
1GUCACGUtt-3#; the coding strands of siRNA duplexes targeting
HhEcto, used as a 1:1 mix, were 5#-GGUAUGUACUAGUUGUGAAtt-
S3# and 5#-GGAAGAAAGAAGAUGUCUCtt-3#.
H
S
Ubiquitination Experiments e
Total cell lysates were prepared by sonication in 25 mM HEPES (pH p
7.9), 0.2 M KCl, 1% NP40, 5 mM EDTA, 1 mM DTT, and 10% gly-
H
cerol with protease, phosphatase, proteasome (100 M MG132,
D
Sigma), and 0.25 g/ml Ubiquitin-aldehyde (Sigma) inhibitors. In-
c
jected Xenopus embryos were lysed in 10 mM HEPES (pH 7.9),
p
0.2 M NaCl, 0.1% NP40, 0.1 mM EGTA, 1 mM DTT, 5% glycerol
B
with inhibitors as above. Prior to immunoprecipitation, lysates were
Lboiled in 1% SDS for 5 min and then diluted to 0.1% SDS with
(0.5% NP40 in phosphate-buffered saline (PBS).
tPlease refer to Supplemental Data for a list of plasmids and de-
scriptions of the experimental procedures for immunoprecipi- L
Ftations and GST pull-downs, pulse-chase, BrdU analysis, immuno-luorescence microscopy, immunohistochemistry, and antibodies
nd Western blotting.
upplemental Data
upplemental Data include 10 figures, Experimental Procedures,
nd References and are available with this article online at http://
ww.cell.com/cgi/content/full/121/1/87/DC1/.
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